ECONOMIC EVALUATION OF VILDAGLIPTIN COMPARED TO GLIMEPIRIDE AS ADD-ON TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN GREECE

被引：2
|
作者：
Hatzikou, M. [1 ]
Rombopoulos, G. [1 ]
Yfantopoulos, J. [2 ]
机构：
[1] Novartis Hellas, Metamorfosis, Greece
[2] Univ Athens, Athens 11528, Greece
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1686
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Song, Young Duk
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Jeong, Choon-hee
    Kim, Byoung-joon
    Park, Kyong Soo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S125 - S126
  • [32] Empagliflozin (EMPA) Compared with Glimepiride (GLIM) as Add-on to Metformin (MET) for 2 Years in Patients with Type 2 Diabetes (T2DM)
    Ridderstrale, Martin
    Andersen, Knut Robert
    Zeller, Cordula
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2014, 63 : A70 - A70
  • [33] Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus
    Forst, T.
    Dworak, M.
    Berndt-Zipfel, C.
    Loeffler, A.
    Klamp, I.
    Mitry, M.
    Pfuetzner, A.
    DIABETES OBESITY & METABOLISM, 2013, 15 (06): : 576 - 579
  • [34] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
  • [35] Liraglutide as add-on to metformin in type 2 diabetes: significant improvement in glycaemic control with a reduction in body weight compared with glimepiride
    Nauck, M
    Hompesch, N
    Filipczak, R
    Le, TTD
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETOLOGIA, 2004, 47 : A281 - A281
  • [36] Liraglutide significantly improves glycemic control and reduces body weight compared with glimepiride as add-on to metformin in type 2 diabetes
    Nauck, MA
    Hompesch, M
    Filipczak, R
    Le, TDT
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETES, 2004, 53 : A83 - A83
  • [37] The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Kim, Gyuri
    Oh, Sewon
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    Lee, Moon-Kyu
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1179 - 1186
  • [38] Economic evaluation of dapagliflozin as add-on to metformin in type 2 diabetes in the Israeli healthcare setting
    Moshel, S.
    Vexberg, M. Hirsch
    Shavit, O.
    Toledano, Y.
    DIABETOLOGIA, 2018, 61 : S311 - S311
  • [39] Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes
    Park, Cheol-Young
    Kang, Jun Goo
    Chon, Suk
    Noh, Junghyun
    Oh, Seung Joon
    Lee, Chang Beom
    Park, Sung Woo
    PLOS ONE, 2014, 9 (03):
  • [40] DIABETES Add-on to metformin in T2DM-linagliptin or glimepiride?
    Christensen, Mikkel
    Knop, Filip K.
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (10) : 576 - 578
12345